MeSH tree: C12.050.351.937.418.875
Endometrial cancer—which develops in the lining of the uterus (womb) and is sometimes called uterine cancer—is on the rise in the U.S. In 1987, there were 35,000 cases annually. That number has nearly doubled in 2023 to more ...
Dec 20, 2023
0
46
QUT scientists have discovered a promising new therapy for a deadly type of endometrial cancer that has a poor prognosis if the cancer spreads or returns after initial treatment, a plight that affects 15%–20% of endometrial ...
Dec 13, 2023
0
42
White women are disproportionately represented in clinical trials for gynecologic cancers, according to a study published online Dec. 7 in JAMA Network Open.
Dec 12, 2023
0
35
The risk of dying from the 10 forms of cancer with the largest death toll for men and women varies massively depending on the district in England where people live, according to a study published in The Lancet Oncology.
Dec 11, 2023
0
34
Published in The Lancet, results of the randomized phase III BEATcc academic trial (ENGOT-Cx10/GEICO 68-C/JGOG1084/GOG-3030) show that adding immune checkpoint inhibitor atezolizumab to standard of care with bevacizumab and ...
Dec 4, 2023
0
36
Pelvic exams are an indispensable part of gynecological care and are used to screen for conditions, such as cervical cancer, that affect millions of patients every year. Unfortunately, pelvic exams can be challenging for ...
Nov 14, 2023
0
37
A new test to detect womb cancer could prevent 87% of women who do not have cancer from needing invasive diagnostic procedures, finds a new study led by researchers at UCL and the University of Innsbruck.
Nov 8, 2023
0
62
Immunotherapy with the anti-PD-L1 monoclonal antibody durvalumab improved progression-free survival (PFS) in patients with newly diagnosed advanced or recurrent endometrial cancer compared with chemotherapy alone, with further ...
Oct 23, 2023
0
42
The U.S. Food and Drug Administration is considering a ban on certain hair-straightening chemicals that have been used by Black women for years and that research shows may increase the risk of uterine cancer.
Oct 19, 2023
0
42
The U.S. Food and Drug Administration has proposed a ban on the use of formaldehyde in hair relaxers over concerns about its link to respiratory problems and certain cancers.
Oct 18, 2023
0
46
